Where does JC Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), JC Medical, Inc. ranks #12,065 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does JC Medical, Inc. hold?

JC Medical, Inc. holds 25 US utility patents granted between 2020 and 2025, spanning 4 technology areas.

What is JC Medical, Inc.'s Innovation Score?

JC Medical, Inc. has an Innovation Score of 38.3 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is JC Medical, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for JC Medical, Inc..

What does claim depth mean for JC Medical, Inc.'s patents?

JC Medical, Inc.'s patents average 18.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the JC Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

JC Medical, Inc.

Q: What technology areas does JC Medical, Inc. focus on?

JC Medical, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 24 patents, ranking #275 of 3,082 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 25 granted patents across 4 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, JC ranks #12,065 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 4 technology areas.

#12,065
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.3/100): 18.9
avg claims per patent

USPTO PatentsView assignee plate

Corpus R12065 · US Corporation #12,065 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 25 grants
UPPER-Q #12,065/49,997
PHOTO-FINISH Invoca
CPC-NARROW A61F · 4 areas
INNOV-THIN 38.3/100
CLAIMS-RICH 18.9 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Invoca, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How JC’s 38.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.3 pts (29%) Velocity 8.7 pts (23%) Breadth 7.1 pts (18%) Claim depth 11.4 pts (30%)

Qualcomm Incorporated · highest

85
Avenu Medical · near

38
JC Medical · this assignee

38
PerkinElmer Health… · near

38
Reliance Controls · near

38
Sensoriant · near

38
3D Lighting… · lowest

7

What this shows JC's Innovation Score is 38.3/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for JC?

Each dot is one of JC’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). JC’s own 18.9 claims/patent is ABOVE the 17.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

JC vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where JC's grants concentrate

JC Medical, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 96% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2022 (9 grants) versus a trough of 2 in 2023. By volume, JC sits between Invoca, Inc. and Jive Software, Inc..

JC's three-year grant acceleration

JC Medical, Inc. shows 13 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Invoca

25
Ionsense

25
J M Huber

25
Janome

25
Jushi Group

25
Javad Gnss

25
Jiangxi Universit…

25
Jive Software

25
JC Medical ◀

25

What this shows JC holds 25 patents at rank #12,062, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near JC

By rank, the assignees closest to #12,062 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in JC's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for JC, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), JC ranks #275 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Reliance Controls Corporation 38 PerkinElmer Health Sciences Canada, Inc. 38 Sensoriant, Inc. 38 Avenu Medical, Inc. 38

JC's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

JC Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	4	16.0%
2021	6	24.0%
2022	9	36.0%
2023	2	8.0%
2024	2	8.0%
2025partial year	2	8.0%

Which technologies does JC Medical, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 24

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 12

B30B - Presses IN General 2

B25B - Tools OR Bench Devices NOT Otherwise Provided FOR, FOR Fastening, Connecting, Disengaging OR Holding 2

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

JC Medical, Inc.'s patent record in context - here's where to go next.

JC Medical, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 96% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #12,065 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare JC Medical, Inc. against Invoca, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.